Life Sciences Interview with Greg Kupp – President Life Sciences Division & Frank Tagliaferri – VP of Technical Development Pace® Life Sciences February 24, 2023
Life Sciences ReveraGen Completes NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy December 21, 2022
Pace Corporate , Life Sciences Pace® Life Sciences Acquires Biopharma Global, Expanding FDA Regulatory Affairs Strategy and Consulting Capabilities to the Biotechnology and Pharmaceutical Markets September 8, 2022
Life Sciences First Wave BioPharma Finalizes Selection of Adrulipase Microgranule Drug Delivery Formulation September 7, 2022
Life Sciences First Wave BioPharma Announces AAPS 2022 PharmSci 360 Accepts Adrulipase Formulation Abstract September 1, 2022
Life Sciences , Scientific Professional Services Pace® Life Sciences Acquires Meridian BioGroup, Expanding Regulatory, Compliance, and Validation Capabilities to the Biotechnology and Pharmaceutical Markets August 18, 2022
Pace Corporate , Life Sciences Pace® Life Sciences Awarded Bronze Medal from EcoVadis for Sustainability Efforts July 6, 2022
Pace Corporate , Life Sciences Webinar: The Evolution of an NCE’s Suspension Formulation, from pre-GLP Studies to the Pharmacy Shelf April 7, 2022
